Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.64 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8049901 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL22240 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL17772493 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL3305087 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL7823853 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL23930717 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL2343127 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL22612526 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL22612511 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD | |
| SCHEMBL5710467 | 1.00 | GPR84 (0.64) | GPR84ACE2FFAR1FFAR4PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | L'OREAL (FR) | 2022-02-15 | — | — | US | claimed |
| CN-106417389-A | Essence for trapping mosquitoes and flies | 天津市双马香精香料新技术有限公司 | 2017-02-22 | — | — | CN | claimed |
| EP-2938654-B1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | OREAL (FR) | 2016-08-24 | — | — | EP | claimed |
| US-20150342868-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | LOREAL (FR) | 2015-12-03 | — | — | US | claimed |
| US-20150320667-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-12 | — | — | US | claimed |
| US-20150320739-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED) (IE) | 2015-11-12 | — | — | US | claimed |
| EP-2938402-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-04 | — | — | EP | claimed |
| EP-2938654-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-04 | — | — | EP | claimed |
| WO-2014102077-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | claimed |
| WO-2014102078-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | claimed |
| US-20130203766-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | SPROUT PHARMACEUTICALS, INC. (US) | 2013-08-08 | — | — | US | claimed |
| US-20110105519-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | SPROUT PHARMACEUTICALS, INC. | 2011-05-05 | — | — | US | claimed |
| US-20080103155-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | SPROUT PHARMACEUTICALS, INC. | 2008-05-01 | — | — | US | claimed |
| EP-1740181-A1 | NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-10 | — | — | EP | claimed |
| US-20050245539-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | US | claimed |
| WO-2005102342-A1 | NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | WO | claimed |
| US-20040044080-A1 | Treatment of dyspareunia with topically administered nitroglycerin formulations | VIVUS, INC. | 2004-03-04 | — | — | US | claimed |
| EP-4610336-A1 | REFRIGERATOR OIL COMPOSITION AND MIXED COMPOSITION FOR REFRIGERATOR | Idemitsu Kosan Co.,Ltd. (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-4083973-A | ANABOLIC ACTIVITY, NANDROLONE | AKZONA INCORPORATED (US) | 1978-04-11 | — | — | US | disclosed |
| US-4071623-A | ESTROGENICALLY ACTIVE STEROIDS | AKZONA INCORPORATED (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103155-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | TAS2R30, TAS1R1, TAS2R10 | GPR84 471/4885ACE2 4321/4885FFAR1 2567/4885 |
| US-20130203766-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20110105519-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20150342868-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | TAS2R30, TAS1R1, TAS2R10 | GPR84 471/4885ACE2 4321/4885FFAR1 2567/4885 |
| US-20150320739-A1 | Pharmaceutical Compositions for the Treatment of Sexual Disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20040044080-A1 | Treatment of dyspareunia with topically administered nitroglycerin formulations | PDE12, PDE3A, PDE2A | GPR84 212/4885ACE2 1720/4885FFAR1 489/4885 |
| US-20050245539-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | FLNB, FLNA, FGB | GPR84 974/4885ACE2 2597/4885FFAR1 594/4885 |
| US-20150320667-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | OR10J3, OR51E2, MSMO1 | GPR84 542/4885ACE2 4721/4885FFAR1 1856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.